BCL2 and myelodysplastic syndrome: In addition, CD34+ cells in HR-MDS show higher expression of anti-apoptotic gene Bcl-2 and lower apoptotic cell related antibody (Apo2.7), which explains why BM cells in HR-MDS are more resistant to apoptosis than those in LR-MDS.